Evidence map›Paper›PMID 41088859›Full record

ReviewProteomics2026

Migrasomes, Matrix-Bound Nanovesicles, and More: Messengers in the Matrix.

Anna V Kolesov, Natalie Reitz, Marley Dewey, Colin L Hisey

Abstract readReview
In one paragraph

Review in Proteomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Anna V KolesovDepartment of Biomedical Engineering, Northwestern University, Evanston, Illinois, USA.
Natalie ReitzDepartment of Biomedical Engineering, Northwestern University, Evanston, Illinois, USA.
Marley DeweyDepartment of Bioengineering, University of California Santa Barbara, Santa Barbara, California, USA.
Colin L HiseyDepartment of Biomedical Engineering, Northwestern University, Evanston, Illinois, USA.ORCID 0000-0001-8732-3600

Funding

Biotechnology Predoctoral Training ProgramT32GM153505 · NIGMS · NORTHWESTERN UNIVERSITY · PI Joshua Nathaniel Leonard · 2024 to 2026
$1.6M
Defining the Role of Matrix-Bound Nanovesicles in Extracellular Matrix Formation and Wound RepairR35GM160216 · NIGMS · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI Marley Johnstone Dewey · 2025 to 2026
$830k
Machine Learning-enabled Classification of Extracellular Vesicles Using Nanoplasmonic MicrofluidicsR00EB033857 · NIBIB · NORTHWESTERN UNIVERSITY · PI Colin Lee Hisey · 2024 to 2026
$668k
National Science Foundation: Materials Research Science and Engineering Center (MRSEC) at UC Santa Barbara NSFDMR-2308708NIBIB NIH HHS R00 EB033857NIGMS NIH HHS R35 GM160216NIGMS NIH HHS T32 GM153505NIH HHS R00EB033857NIH HHS R35GM160216NIH HHS T32GM153505Northwestern University's Biotechnology Training Program
6 · The paper itself

Abstract

Extracellular vesicles (EVs) and particles (EPs) are diverse micro- and nanoparticles that circulate in bodily fluids and can attach to, or be deposited onto, the extracellular matrix (ECM) and other surfaces. To date, the nomenclature and classification of matrix-bound or matrix-associated EVs and EPs (MEVPs) have been unclear, largely due to a lack of consensus guidelines and a relatively miniscule amount of received attention in comparison to EVs found in fluids. Recently, there has been a growing appreciation for several subtypes of MEVPs and their roles in applications ranging from wound healing to metastasis. However, progress in these fields has largely been achieved in silos, with minimal consideration for overlap or complementary function between different MEVPs. In this article, we briefly describe this growing field with a focus on several MEVP subtypes and the lack of consensus, then discuss challenges and opportunities in improving MEVP isolation and characterization. Importantly, proteomic analyses of these unique MEVPs will be crucial in promoting rigor, reproducibility, and understanding in this exciting new field.

Indexed as

Extracellular MatrixExtracellular VesiclesAnimalsHumansNanoparticlesProteomicsextracellular matrixextracellular vesiclesmatrix vesiclesmigrasomesproteomics

Identifiers

PMID41088859
PMCPMC13063835

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.